July 2018 FDA Recall Metformin Hydrochloride by Sun Pharmaceutical Industries, Inc.
D-0924-2018 - Presence of foreign substance

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on July 3, 2018 for the product Metformin Hydrochloride. The FDA reported the reason for recall as presence of foreign substance. The product was distributed in AZ and the recall is currently terminated.

Recall Number: D-0924-2018

Reason for Recall
Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.
Initiated
07-03-2018
Reported
07-25-2018
Quantity
2508 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sun Pharmaceutical Industries, Inc.
Metformin Hydrochloride Extended Release Tablets, USP, 500 mg, packaged in a 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat. India, NDC 62756-142-02

Batch or Lot Expiration Information

Lot# : JKT0042A, Exp 1/2021